Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD Registry, 2019-2020.

Nicholas SB, Daratha KB, Alicic RZ, Jones CR, Kornowske LM, Neumiller JJ, Fatoba ST, Kong SX, Singh R, Norris KC, Tuttle KR. Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD Registry, 2019-2020. Diabetes Obes Metab. 2023 10; 25(10):2970-2979.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Aged, 80 and over
Angiotensin-Converting Enzyme Inhibitors
Creatinine
Diabetes Mellitus
Diabetes Mellitus, Type 2
Female
Humans
Male
Middle Aged
Prescriptions
Registries
Renal Insufficiency, Chronic

authors with profiles

Keith Norris

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support